Condition: Covid19 · Arterial Stiffness · Endothelial Dysfunction · Sponsor: Assistance Publique - Hôpitaux de Paris
The purpose of the study is to evaluate the presence of early vascular aging 6 months and 12 months after COVID-19 infection.
This description comes directly from the study's public registry record.
Rosa Maria BRUNO, MD · +33 1 53 98 79 67 · rosa-maria.bruno@inserm.fr
Laura LE MAO, MSc · +33 1 56 09 54 97 · laura.le-mao@aphp.fr
Always discuss trial participation with your own doctor first.
| CHRU Nancy | Nancy, France | Recruiting |
| Hôpital Européen Georges Pompidou - APHP | Paris, France | Recruiting |
| CHU Rouen | Rouen, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04558450